Equities

Nihon Kohden Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Nihon Kohden Corp

Actions
  • Price (USD)10.90
  • Today's Change0.00 / 0.00%
  • Shares traded2.33k
  • 1 Year change--
  • Beta0.4734
Data delayed at least 15 minutes, as of Feb 05 2026 18:24 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

NIHON KOHDEN CORPORATION is a Japan-based company engaged in the research, development, manufacture and sale of medical electronic equipment, as well as the provision of maintenance and repair services. The Company mainly operates medical electronics related business. The Company offers electroencephalograph, electromyographic, evoked potential testing equipment, electrocardiographs, cardiac catheterization equipment, diagnostic information systems and related consumables (paper, electrodes, catheters and others), biological information monitors, clinical information systems, artificial respiration, artificial ear, hemocytometer, ultrasonic diagnostic equipment, research equipment and transformers, among others. The Company is also engaged in the sales promotion for its products, as well as the general affair-related and manpower dispatching businesses.

  • Revenue in JPY (TTM)230.96bn
  • Net income in JPY12.37bn
  • Incorporated1951
  • Employees6.11k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
6849:TYO since
announced
Transaction
value
DOWELL Co LtdAnnounced14 Jan 202614 Jan 2026Announced-8.19%--
Data delayed at least 15 minutes, as of Feb 06 2026 06:30 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.